Table 1 lists various assessment tools used in the reviewed trials to measure the primary and secondary outcomes. Table 2 summarizes the primary endpoints and adverse events observed in these trials.

In the United States, black patients face barriers in access to many types of healthcare, leading to significant healthcare disparities. Recognition and analysis of potential barriers to access could ...

Researchers at the University of Alabama at Birmingham studied the impact of unilateral DBS on verbal fluency in Parkinson’s patients. Findings showed that electrode implants in the left hemisphere of ...

“To the best of our team's knowledge, this project represents the first time an Alabama medical center has examined deep ...

Researchers at UC San Francisco have developed a new way to improve walking for patients with Parkinson’s Disease using deep brain stimulation and artificial intelligence. Deep brain stimulation (DBS) ...

Patients who lose the use of their hands and arms after a stroke or traumatic brain injury could regain some function through deep brain stimulation (DBS), new research demonstrates. Photo by Adobe ...

The post Researchers at Israeli hospital develop new schizophrenia therapy appeared first on The Times of Israel.

Medical tech company Medtronic has just landed FDA clearance on its Deep Brain Stimulation (DBS) Clinical Programmer and ActivaProgramming application. "This marks a new era of innovation from the ...

New research suggests that paralyzed patients could regain some degree of movement — perhaps even walk again. In a study led by EPFL (Swiss Federal Technology Institute of Lausanne) and Lausanne ...